Colin Sutherland studied Zoology and Genetics at the University of Sydney, and gained a PhD in gene expression studies during mammalian muscle development in 1992. Colin joined LSHTM in January 1998 to work as a Post-Doc with Professor Geoffrey Targett on the gametocytes of Plasmodium falciparum. Colin also developed an interest in parasite drug resistance in the context of the team’s clinical studies in The Gambia from 1998 – 2002. From 2004 – 2011, Colin continued his studies of parasite drug susceptibility, and also developed new projects on molecular diagnostics for parasitology with Peter Chiodini and Spencer Polley in the Department of Clinical Parasitology at the Hospital for Tropical Diseases. This work now continues with Public Health England in the PHE Malaria Reference Laboratory, LSHTM, where Colin is HCPC-registered as a Clinical Scientist.

Current research projects include K13-independent mechanisms of artemisinin resistance in Plasmodium falciparum, drug susceptibility of P. knowlesi and the genetics of ovale malaria.

Among Colin’s current roles are:

• Co-Director, LSHTM Malaria Centre
• Deputy Director (Science), PHE Malaria Reference Laboratory, LSHTM
• Editorial Board Member for the Journal of Antimicrobial Chemotherapy
• Vice-President, British Society for Parasitology